{
  "pmcid": "12426121",
  "sha256": "c0fa7d12872fad9c2e070140102ad7a6de29d0b61fa891e409cdbc591d348265",
  "timestamp_utc": "2025-11-09T23:37:30.173894+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.557234753550542,
    "reading_ease": 21.48718045112784,
    "word_count": 252
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Ultrasound Technology in Therapeutic Applications"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This randomised controlled trial was conducted in a clinical setting."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were eligible if they had musculoskeletal or tumor conditions."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received ultrasound therapy, while the control group received standard care."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assesses its efficacy in enhancing drug delivery and therapeutic outcomes."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the enhancement of drug delivery, measured over a 6-month period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment using sealed envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was applied to outcome assessors, patients, and clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention and 100 to the control group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis included 98 participants in the intervention group and 97 in the control group, using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group showed a significant improvement in drug delivery (mean difference = 5.2, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild, with 3% in the intervention group and 1% in the control group experiencing side effects."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678"
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by the National Institutes of Health."
      }
    },
    "total_score": 25,
    "max_score": 25
  }
}